Protein-Protein Interactions (PPIs) are critical for biological systems to function properly. Strong interactions maintain structural integrity and function, whereas weaker interactions enable ...

A bizarre fossil called Prototaxites, which was the largest life-form on land 400 million years ago, may have been a completely unknown form of multicellular life, according to a new study.

Disruption of fatty acid storage triggers tumor cell death in preclinical models of high-risk medulloblastoma, offering a ...

Scientists Discover a New Form of Life Standing 26 Feet Tall ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...

A meta-analysis of more than 20 phase 3 trials found no clear survival differences by sex or age in metastatic NSCLC but reported better outcomes for Asian patients and continued underrepresentation ...

Neoadjuvant immunotherapy could considerably improve long-term outcomes and quality of life for patients with desmoplastic melanoma, according to prospective study results.Nearly three-quarters of ...

Biochemistry Professor Andy LiWang may have uncovered a universal mechanism that explains how bacteria, and potentially many other organisms, adapt to changes in temperature. If the hypothesis holds, ...

In clinical trials, weight loss with GLP-1 medications tends to follow a predictable curve: rapid early losses during drug initiation and dose increases, a gradual slowing and eventual plateau. A ...

Jim Tananbaum, MD, Foresite Capital’s founder and CEO, and Michael Rome, PhD, the managing director who leads the firm’s therapeutics investing practice, discuss the firm’s approach to nurturing ...

Filing acceptance based on Phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, versus ...